DocGo (DCGO) 10-Q 25 Nov 20 2020 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	2 Months Ended
	Sep. 30, 2020	Nov. 25, 2020
Document Information Line Items
Entity Registrant Name	Motion Acquisition Corp.
Document Type	10-Q
Current Fiscal Year End Date	--12-31
Amendment Flag	false
Entity Central Index Key	0001822359
Entity Current Reporting Status	No
Entity Filer Category	Non-accelerated Filer
Document Period End Date	Sep. 30, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Shell Company	true
Entity Ex Transition Period	false
Entity Incorporation, State or Country Code	DE
Entity File Number	001-39618
Document Transition Report	false
Entity Interactive Data Current	Yes
Class A Common Stock
Document Information Line Items
Entity Common Stock, Shares Outstanding		11,500,000
Class B Common Stock
Document Information Line Items
Entity Common Stock, Shares Outstanding		2,875,000

Unaudited Condensed Balance She

Unaudited Condensed Balance Sheet	Sep. 30, 2020USD ($)
Assets:
Cash	$ 1,532
Total Current Assets	1,532
Deferred offering costs associated with initial public offering	113,016
Total Assets	114,548
Current liabilities:
Accounts payable	20,450
Note payable to related party	71,163
Total Current Liabilities	91,613
Commitments and Contingencies
Stockholder’s Equity:
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
Additional paid-in capital	24,669
Accumulated deficit	(2,065)
Total Stockholder’s Equity	22,935
Total Liabilities and Stockholder’s Equity	114,548
Class A Common Stock [Member]
Stockholder’s Equity:
Common stock
Total Stockholder’s Equity
Class B Common Stock [Member]
Stockholder’s Equity:
Common stock	331	[1],[2]
Total Stockholder’s Equity	$ 331
[1]	On October 14, 2020, the Sponsor effected a surrender of 431,250 Class B common shares to the Company for no consideration, resulting in a decrease in the total number of Class B common shares then outstanding from 3,737,500 to 3,306,250. All shares and associated amounts have been retroactively restated to reflect the share surrender (see Note 4).
[2]	Outstanding share amount included an aggregate of up to 431,250 Class B common shares that were subject to forfeiture depending on whether the underwriter’s over-allotment option was exercised (see Note 3).

Unaudited Condensed Balance S_2

Unaudited Condensed Balance Sheet (Parentheticals)	Sep. 30, 2020$ / sharesshares
Preferred stock par value (in Dollars per share) | $ / shares	$ 0.0001
Preferred stock, shares authorized	1,000,000
Preferred stock, shares issued	0
Preferred stock, shares outstanding	0
Class A Common Stock [Member]
Common stock, par value (in Dollars per share) | $ / shares	$ 0.0001
Common stock, shares authorized	50,000,000
Common stock, shares issued	0
Common stock, shares outstanding	0
Class B Common Stock [Member]
Common stock, par value (in Dollars per share) | $ / shares	$ 0.0001
Common stock, shares authorized	12,500,000
Common stock, shares issued	3,306,250
Common stock, shares outstanding	3,306,250

Unaudited Condensed Statement o

Unaudited Condensed Statement of Operations	2 Months Ended
	Sep. 30, 2020USD ($)$ / sharesshares
Income Statement [Abstract]
General and administrative expenses	$ 2,065
Net loss	$ (2,065)
Weighted average Class B shares outstanding, basic and diluted (in Shares) | shares	2,875,000	[1],[2]
Basic and diluted net loss per Class B share (in Dollars per share) | $ / shares	$ 0
[1]	On October 14, 2020, the Sponsor effected a surrender of 431,250 Class B common shares to the Company for no consideration, resulting in a decrease in the total number of Class B common shares then outstanding from 3,737,500 to 3,306,250. All shares and associated amounts have been retroactively restated to reflect the share surrender (see Note 4).
[2]	Weighted average shares outstanding amount excludes an aggregate of up to 431,250 Class B common shares that were subject to forfeiture depending on whether the underwriter’s over-allotment option was exercised (see Note 3).

Unaudited Condensed Statement_2

Unaudited Condensed Statement of Changes in Stockholder’s Equity - 2 months ended Sep. 30, 2020 - USD ($)		Class A Common Stock	Class B Common Stock	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Aug. 10, 2020
Balance (in Shares) at Aug. 10, 2020
Issuance of Class B common stock to related party	[1],[2]		$ 331	24,669		25,000
Issuance of Class B common stock to related party (in Shares)	[1],[2]		3,306,250
Net loss					(2,065)	(2,065)
Balance at Sep. 30, 2020			$ 331	$ 24,669	$ (2,065)	$ 22,935
Balance (in Shares) at Sep. 30, 2020			3,306,250
[1]	On October 14, 2020, the Sponsor effected a surrender of 431,250 Class B common shares to the Company for no consideration, resulting in a decrease in the total number of Class B common shares then outstanding from 3,737,500 to 3,306,250. All shares and associated amounts have been retroactively restated to reflect the share surrender (see Note 4).
[2]	Outstanding share amount included an aggregate of up to 431,250 Class B common shares that were subject to forfeiture depending on whether the underwriter’s over-allotment option was exercised (see Note 3).

Unaudited Condensed Statement_3

Unaudited Condensed Statement of Cash Flows	2 Months Ended
	Sep. 30, 2020USD ($)
Cash Flows from Operating Activities:
Net loss	$ (2,065)
Adjustments to reconcile net loss to net cash used in operating activities:
Changes in operating assets and liabilities
Net cash used in operating activities	(2,065)
Cash flow from financing activities:
Proceeds from note payable to related party	71,163
Payment of deferred offering costs	(67,566)
Net cash provided by financing activities	3,597
Net change in cash	1,532
Cash - beginning of the period
Cash - end of the period	1,532
Supplemental disclosure of noncash activities:
Deferred offering costs paid by related party in exchange for issuance of Class B common stock	25,000
Deferred offering costs included in accounts payable	$ 20,450

Organization, Business Operatio

Organization, Business Operations and Basis of Presentation	2 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
ORGANIZATION, BUSINESS OPERATIONS AND BASIS OF PRESENTATION	NOTE 1. ORGANIZATION, BUSINESS OPERATIONS AND BASIS OF PRESENTATION Incorporation Motion Acquisition Corp. (the “Company”) was incorporated as a Delaware corporation on August 11, 2020. The Company’s sponsor is Motion Acquisition LLC, a Delaware limited liability company (the “Sponsor”). Fiscal Year End The Company has selected December 31 as its fiscal year end. Business Purpose The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination (“Business Combination”) with one or more businesses or entities that it has not yet selected (a “target business”). Although the Company is not limited to a particular industry or sector for purposes of consummating a Business Combination, the Company is initially focusing its search on target businesses in the connected vehicle industry The Company’s management has broad discretion with respect to the specific application of the net proceeds of its initial public offering of units (the “Initial Public Offering”), although substantially all of the net proceeds of the Initial Public Offering are intended to be generally applied toward completing a Business Combination. Furthermore, there is no assurance that the Company will be able to successfully complete a Business Combination. Financing The registration statement for the Company’s Initial Public Offering was declared effective on October 14, 2020. On October 19, 2020, the Company consummated its Initial Public Offering of 11,500,000 units (the “Units” and, with respect to the Class A common stock included in the Units being offered, the “Public Shares”) at $10.00 per Unit, generating gross proceeds of $115.0 million, and incurring offering costs of approximately $6.7 million, inclusive of $4.0 million in deferred underwriting commissions (Note 3). Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 2,533,333 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”) at a price of $1.50 per Private Placement Warrant in a private placement to the Sponsor, generating gross proceeds of $3.8 million (Note 4). The Company granted the underwriter a 45-day option from the date of Initial Public Offering to purchase up to 1,725,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. On November 16, 2020, the underwriter advised the Company that it will not exercise the over-allotment option (Note 3). Trust Account Upon the closing of the Initial Public Offering and the Private Placement, $115.0 million ($10.00 per Unit) of the net proceeds of the sale of the Units in the Initial Public Offering and Private Placement Warrants in the Private Placement were placed in a trust account (“Trust Account”) located in the United States with Continental Stock Transfer & Trust Company acting as trustee. The proceeds held in the Trust Account will either be held as cash or invested only in U.S. “government securities,” within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or in money market funds meeting certain conditions under the Investment Company Act, which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below. Pursuant to stock exchange listing rules, the Company must complete an initial Business Combination with one or more target businesses that together have an aggregate fair market value of at least 80% of the assets held in the Trust Account (as defined below) (excluding the deferred underwriting commissions and taxes payable on the income earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). The Company’s amended and restated certificate of incorporation provides that, other than the withdrawal of interest earned on the funds that may be released to the Company to pay taxes, none of the funds held in the Trust Account will be released until the earliest of: (i) the completion of the Business Combination; (ii) the redemption of any of Public Shares to its holders (the “Public Stockholders”) properly tendered in connection with a stockholder vote to amend certain provisions of the Company’s amended and restated certificate of incorporation prior to an initial Business Combination and (iii) the redemption of 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below). The Company, after signing a definitive agreement for a Business Combination, will either (i) seek stockholder approval of the Business Combination at a meeting called for such purpose in connection with which Public Stockholders may seek to redeem their Public shares, regardless of whether they vote for or against the Business Combination or do not vote at all, for cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the initial Business Combination, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes, or (ii) provide the Public Stockholders with the opportunity to sell their shares to the Company by means of a tender offer for an amount in cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation of the initial Business Combination, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes. As a result, such common stock will be recorded at redemption amount and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standard Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity.” The amount in the Trust Account is initially anticipated to be $10.00 per Public Share. Except as required by applicable law, the decision as to whether the Company will seek stockholder approval of the Business Combination or will allow stockholders to sell their shares in a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would otherwise require the Company to seek stockholder approval. If the Company seeks stockholder approval, it will complete its Business Combination only if a majority of the outstanding shares of common stock voted are voted in favor of the Business Combination. However, in no event will the Company redeem its Public Shares in an amount that would cause its net tangible assets to be less than $5,000,001 either immediately prior to or upon consummation of the Company’s initial Business Combination. In such case, the Company would not proceed with the redemption of its Public Shares and the related Business Combination, and instead may search for an alternate Business Combination. The Company will have 24 months from the closing of the Initial Public Offering, or October 19, 2022, to complete its initial Business Combination (the “Combination Period”). If the Company does not complete a Business Combination within this period of time (and stockholders do not approve an amendment to the Company’s amended and restated certificate of incorporation to extend this date), it will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Stockholder’s rights as stockholders (including the right to receive further liquidating distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in the case of clauses (ii) and (iii) to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. The Company’s Sponsor and the Company’s officers and directors have entered into agreements with the Company, pursuant to which they have waived their rights to participate in any redemption with respect to their Founder Shares (as defined below) in the event the Company does not complete a Business Combination within the required time period; provided, however, if the Sponsor or any of the Company’s officers, directors or affiliates acquire Public Shares after the Initial Public Offering, they will be entitled to a pro rata share of the Trust Account upon the Company’s redemption or liquidation in the event the Company does not complete a Business Combination within the Combination Period. In the event of such distribution, it is possible that the per share value in the Trust Account will be less than the Initial Public Offering price per Unit in the Initial Public Offering. Liquidity and Capital Resources As of September 30, 2020, the Company had cash of approximately $2,000 and a working capital deficit of approximately $90,000. Prior to September 30, 2020, the Company’s liquidity needs were satisfied through a payment of $25,000 from the Company’s Chief Executive Officer to fund certain offering costs in exchange for the issuance of the Founder Shares (as defined below) to the Sponsor, and advances to the Company from the Sponsor of approximately $71,000 under a note payable (the “Note Payable”) (see Note 4) to pay for other offering costs in connection with the Initial Public Offering. Subsequent to September 30, 2020, the liquidity needs have been satisfied from the net proceeds of the consummation of the Private Placement not held in the Trust Account. The Company fully repaid the Note Payable on October 19, 2020. In addition, in order to finance transaction costs in connection with a Business Combination, the Company’s officers, directors and initial stockholders may, but are not obligated to, provide the Company Working Capital Loans (see Note 4). To date, there were no amounts outstanding under any Working Capital Loans. Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination. Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that the specific impact is not readily determinable as of the date of the unaudited condensed financial statements. The financial statement does not include any adjustments that might result from the outcome of this uncertainty. Basis of Presentation The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the period presented. Operating results for the period from August 11, 2020 (inception) through September 30, 2020 are not necessarily indicative of the results that may be expected through December 31, 2020 or any future period. The accompanying unaudited condensed financial statements should be read in conjunction with the final prospectus and the audited balance sheet and notes thereto included in the Form 8-K filed by the Company with the SEC on October 16, 2020 and October 23, 2020, respectively. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Significant Accounting Policies

Significant Accounting Policies	2 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
SIGNIFICANT ACCOUNTING POLICIES	NOTE 2. SIGNIFICANT ACCOUNTING POLICIES Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times, may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet primarily due to their short-term nature. Use of Estimates The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Deferred Offering Costs Associated with the Initial Public Offering The Company complies with the requirements of the ASC 340-10-S99-1. Offering costs consist of legal, accounting, and other costs incurred through the balance sheet date that were directly related to the Initial Public Offering and that were charged to stockholder’s equity upon the completion of the Initial Public Offering. Net Loss Per Share Net loss per share of common stock is computed by dividing net loss applicable to stockholders by the weighted average number of shares of common stock outstanding during the period, plus to the extent dilutive the incremental number of shares of common stock to settle warrants, as calculated using the treasury method. Weighted average shares were reduced by an aggregate of 431,250 shares for the Class B of common stock that were forfeited in November 2020 as a result of the underwriter’s election to not exercise the over-allotment option. At September 30, 2020, the Company did not have any dilutive securities and other contracts that could potentially be exercised or converted into common stock and then share in the earnings of the Company under the treasury method. As a result, diluted loss per share of common stock is the same as basic loss per share of common stock for the period presented. Income Taxes The Company complies with the accounting and reporting requirements of Financial Accounting Standards Board Accounting Standard Codification, or FASB ASC 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. There were no unrecognized tax benefits as of September 30, 2020. FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties at September 30, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The provision for income taxes was deemed to be de minimis for the period from August 11, 2020 (inception) through September 30, 2020. Recent Accounting Pronouncements Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

Initial Public Offering

Initial Public Offering	2 Months Ended
	Sep. 30, 2020
Initial Public Offering [Abstract]
INITIAL PUBLIC OFFERING	NOTE 3. INITIAL PUBLIC OFFERING Public Units On October 19, 2020, the Company consummated its Initial Public Offering of 11,500,000 Units at $10.00 per Unit, generating gross proceeds of $115.0 million, and incurring offering costs of approximately $6.7 million, inclusive of $4.0 million in deferred underwriting commissions. Upon the closing of the Initial Public Offering and the Private Placement, $115.0 million ($10.00 per Unit) of the net proceeds of the sale of the Units in the Initial Public Offering and the Private Placement Warrants in the Private Placement were placed in the Trust Account. Each Unit consists of one of the Company’s shares of Class A common stock, $0.0001 par value, and one-third of one redeemable warrant (the “Public Warrants” and, collectively with the Private Placement Warrants, the “Warrants”). Each whole Public Warrant entitles the holder to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment under certain circumstances. Underwriting Agreement The Company granted the underwriter a 45-day option to purchase up to 1,725,000 additional Units to cover any over-allotments, at the Initial Public Offering price less the underwriting discounts and commissions. On November 16, 2020, the underwriter advised the Company that it will not exercise the over-allotment option. Consequently, 431,250 Class B common shares were forfeited, resulting in a decrease in the total number of Class B common shares outstanding from 3,306,250 to 2,875,000, such that the Founder Shares (as defined below) will represent 20.0% of the Company’s issued and outstanding shares after the Initial Public Offering. The underwriter was entitled to an underwriting discount of $0.20 per unit, or $2.3 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or approximately $4.0 million in the aggregate, will be payable to the underwriter for deferred underwriting commissions from the amounts held in the Trust Account solely in the event that the Company completes an initial Business Combination, subject to the terms of the underwriting agreement.

Related Party Transactions

Related Party Transactions	2 Months Ended
	Sep. 30, 2020
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 4. RELATED PARTY TRANSACTIONS Founder Shares On August 12, 2020, the Company’s Chief Executive Officer paid for certain offering costs for an aggregate price of $25,000 in exchange for issuance of 3,737,500 shares of Class B common stock, par value $0.0001 per share (the “Founder Shares”), issued to the Sponsor. On October 14, 2020, the Sponsor effected a surrender of 431,250 Class B common shares to the Company for no consideration, resulting in a decrease in the total number of Class B common shares outstanding from 3,737,500 to 3,306,250 such that the Founder Shares will represent 20.0% of the Company’s issued and outstanding shares after the Initial Public Offering shares will be allocated among the Company’s officers, certain directors as well as to certain third parties. The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earlier to occur of: (A) one year after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, (x) if the last reported sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property. Private Placement Warrants Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 2,533,333 Private Placement Warrants at a price of $1.50 per Private Placement Warrants, generating gross proceeds of $3.8 million in the Private Placement. Each Private Placement Warrant is exercisable for one whole share of Class A common stock at a price of $11.50 per share, subject to adjustment. A portion of the proceeds from the sale of the Private Placement Warrants was added to the net proceeds from the Initial Public Offering to be held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Placement Warrants will be non-redeemable for cash (subject to certain exceptions) and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees. The Private Placement Warrants (and the Class A common stock issuable upon exercise of the Private Placement Warrants) will not be transferable, assignable or salable until 30 days after the completion of the initial Business Combination (subject to certain exceptions). Related Party Loans On August 18, 2020, the Sponsor agreed to loan the Company up to an aggregate of $150,000 pursuant to an unsecured Note Payable to cover expenses related to the Initial Public Offering. This loan was payable without interest upon the completion of the Initial Public Offering. As of September 30, 2020, the Company borrowed approximately $71,000 under the Note Payable. The Company fully repaid the Note Payable on October 19, 2020. Working Capital Loans In order to fund working capital deficiencies or finance transaction costs in connection with an intended initial Business Combination, the initial stockholders, officers and directors and their affiliates may, but are not obligated to, loan the Company funds as may be required (the “Working Capital Loans”). Up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.50 per warrant at the option of the lender. Such warrants would be identical to the Private Placement Warrants. Except for the foregoing, the terms of such loans, if any, have not been determined and no written agreements exist with respect to such loans to date. The Company had no borrowings under the Working Capital Loans at September 30, 2020.

Commitments and Contingencies

Commitments and Contingencies	2 Months Ended
	Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 5. COMMITMENTS AND CONTINGENCIES Registration Rights The Sponsor is entitled to registration rights with respect to the Founder Shares, Private Placement Warrants and any additional warrants that may be issued upon conversion of working capital loans pursuant to a registration rights agreement. The Sponsor will be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities for sale under the Securities Act. In addition, Sponsor will have “piggy-back” registration rights to include their securities in other registration statements filed by the Company. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Stockholder's Equity

Stockholder's Equity	2 Months Ended
	Sep. 30, 2020
Stockholders' Equity Note [Abstract]
STOCKHOLDER'S EQUITY	NOTE 6. STOCKHOLDER’S EQUITY Class A Common Stock Class B Common Stock On August 13, 2020, the Company issued 3,737,500 Class B common shares to the Sponsor. On October 14, 2020, the Sponsor effected a surrender of 431,250 Class B common shares to the Company for no consideration, resulting in a decrease in the total number of Class B common shares outstanding from 3,737,500 to 3,306,250. All shares and associated per share amounts have been retroactively restated to reflect this share surrender. such that the Founder Shares will represent 20.0% of the Company’s issued and outstanding shares after the Initial Public Offering The shares of Class B common stock will automatically convert into shares of Class A common stock at the time of the initial Business Combination, or earlier at the option of the holder, on a one-for-one basis (subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and the like, and subject to further adjustment as described herein). In the case that additional shares of Class A common stock, or equity-linked securities, are issued or deemed issued in excess of the amounts issued in the Initial Public Offering and related to the closing of the initial Business Combination (including pursuant to a specified future issuance), the ratio at which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the then-outstanding shares of Class B common stock agree to waive such adjustment with respect to any such issuance or deemed issuance, including pursuant to a specified future issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all shares of common stock outstanding upon the completion of the Initial Public Offering plus all shares of Class A common stock and equity-linked securities issued or deemed issued in connection with our initial Business Combination (excluding any shares or equity-linked securities issued or issuable to any seller in the initial Business Combination). Preferred stock Warrants The Warrants will have an exercise price of $11.50 per share, subject to adjustment, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per share (as adjusted for stock splits, stock dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors, and in the case of any such issuance to the Company’s initial stockholders, officers, directors or their affiliates, without taking into account any Founder Shares held by them prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s shares of Class A common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of each Warrant will be adjusted (to the nearest cent) such that the effective exercise price per full share will be equal to 115% of the higher of (i) the Market Value and (ii) the Newly Issued Price, and the $18.00 per-share redemption trigger price described below will be adjusted (to the nearest cent) to be equal to 180% of the higher of (i) the Market Value and (ii) the Newly Issued Price. The Private Placement Warrants are identical to the Public Warrants, except that (1) the Private Placement Warrants and the shares of Class A common stock issuable upon exercise of the Private Placement Warrants will not be transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions, (2) the Private Placement Warrants will be non-redeemable (subject to certain exceptions) and exercisable on a cashless basis so long as they are held by the Sponsor or its permitted transferees and (3) the Sponsor and its permitted transferees will also have certain registration rights related to the Private Placement Warrants (including the shares of Class A common stock issuable upon exercise of the Private Placement Warrants). If the Private Placement Warrants are held by someone other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. Once the Warrants become exercisable, the Company may redeem the outstanding Warrants (except for the Private Placement Warrants): ● in whole and not in part; ● at a price of $0.01 per Warrant; ● upon a minimum of 30 days’ prior written notice of redemption; and ● if, and only if, the last reported sale price of the Class A common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period commencing once the Warrants become exercisable and ending on the third trading day prior to the date on which the Company sends the notice of redemption to the Warrant holders. If the Company calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. Commencing ninety days after the Warrants become exercisable, the Company may redeem the outstanding Warrants: ● in whole and not in part; ● at $0.10 per Warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their Warrants on a cashless basis prior to redemption and receive that number of shares of Class A common stock to be determined by reference to an agreed table based on the redemption date and the “fair market value” of the Company’s Class A common stock; ● if, and only if, the last reported sale price of the Company’s Class A common stock equals or exceeds $10.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) on the trading day prior to the date on which the Company sends the notice of redemption to the Warrant holders; ● if, and only if, the Private Placement Warrants are also concurrently called for redemption on the same terms as the outstanding Public Warrants, as described above; and ● if, and only if, there is an effective registration statement covering the issuance of the shares of Class A common stock (or a security other than the Class A common stock into which the Class A common stock has been converted or exchanged for in the event the Company is not the surviving company in the initial Business Combination) issuable upon exercise of the Warrants and a current prospectus relating thereto available throughout the 30-day period after written notice of redemption is given. The “fair market value” of the Class A common stock for this purpose shall mean the average last reported sale price of the Class A common stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of Warrants. In no event will the Company be required to net cash settle any Warrant. If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of Warrants will not receive any of such funds with respect to their Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such Warrants. Accordingly, the Warrants may expire worthless.

Subsequent Events

Subsequent Events	2 Months Ended
	Sep. 30, 2020
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 7. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred up to the date unaudited condensed financial statements were issued. Based upon this review, the Company determined that, except as disclosed in Note 4, there have been no events that have occurred that would require adjustments to the disclosures in the unaudited condensed financial statements.

Accounting Policies, by Policy

Accounting Policies, by Policy (Policies)	2 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentration of credit risk consist of cash accounts in a financial institution which, at times, may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet primarily due to their short-term nature.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
Deferred Offering Costs Associated with the Initial Public Offering	Deferred Offering Costs Associated with the Initial Public Offering The Company complies with the requirements of the ASC 340-10-S99-1. Offering costs consist of legal, accounting, and other costs incurred through the balance sheet date that were directly related to the Initial Public Offering and that were charged to stockholder’s equity upon the completion of the Initial Public Offering.
Net Loss Per Share	Net Loss Per Share Net loss per share of common stock is computed by dividing net loss applicable to stockholders by the weighted average number of shares of common stock outstanding during the period, plus to the extent dilutive the incremental number of shares of common stock to settle warrants, as calculated using the treasury method. Weighted average shares were reduced by an aggregate of 431,250 shares for the Class B of common stock that were forfeited in November 2020 as a result of the underwriter’s election to not exercise the over-allotment option. At September 30, 2020, the Company did not have any dilutive securities and other contracts that could potentially be exercised or converted into common stock and then share in the earnings of the Company under the treasury method. As a result, diluted loss per share of common stock is the same as basic loss per share of common stock for the period presented.
Income Taxes	Income Taxes The Company complies with the accounting and reporting requirements of Financial Accounting Standards Board Accounting Standard Codification, or FASB ASC 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. There were no unrecognized tax benefits as of September 30, 2020. FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties at September 30, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. The provision for income taxes was deemed to be de minimis for the period from August 11, 2020 (inception) through September 30, 2020.
Recent Accounting Pronouncements	Recent Accounting Pronouncements Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

Organization, Business Operat_2

Organization, Business Operations and Basis of Presentation (Details) - USD ($)		1 Months Ended	2 Months Ended
		Oct. 19, 2020	Sep. 30, 2020
Organization, Business Operations and Basis of Presentation (Details) [Line Items]
Gross proceeds	[1],[2]		$ 25,000
Percentage of fair market value of assets held in trust account			80.00%
Business Acquisition, Percentage of Voting Interests Acquired			50.00%
Percentage of redemption of public shares			100.00%
Amout of anticipated per public share (in Dollars per share)			$ 10
Net tangible asset cause by redeem of public shares			$ 5,000,001
Interest to pay dissolution expenses			100,000
Cash			2,000
Amount of working capital deficit			90,000
Payment to satisfied liquidity needs			$ 25,000
Warrants [Member]
Organization, Business Operations and Basis of Presentation (Details) [Line Items]
Number of units issued (in Shares)			2,533,333
Sponsor [Member]
Organization, Business Operations and Basis of Presentation (Details) [Line Items]
Advance under notes payable			$ 71,000
Initial Public Offering [Member]
Organization, Business Operations and Basis of Presentation (Details) [Line Items]
Net proceeds from sale of units			$ 115,000,000
Net proceeds per unit (in Dollars per share)			$ 10
Initial Public Offering [Member] | Subsequent Event [Member]
Organization, Business Operations and Basis of Presentation (Details) [Line Items]
Amount of deferred underwriting commissions		$ 4,000,000
Initial Public Offering [Member] | Over allotments [Member]
Organization, Business Operations and Basis of Presentation (Details) [Line Items]
Number of additional units purchased (in Shares)			1,725,000
Private Placement [Member] | Warrants [Member]
Organization, Business Operations and Basis of Presentation (Details) [Line Items]
Number of units issued (in Shares)			2,533,333
Price per unit (in Dollars per share)			$ 1.50
Gross proceeds			$ 3,800,000
Common Class A [Member]
Organization, Business Operations and Basis of Presentation (Details) [Line Items]
Number of units issued (in Shares)	[1],[2]
Gross proceeds	[1],[2]
Common Class A [Member] | Initial Public Offering [Member] | Subsequent Event [Member]
Organization, Business Operations and Basis of Presentation (Details) [Line Items]
Number of units issued (in Shares)		11,500,000
Price per unit (in Dollars per share)		$ 10
Gross proceeds		$ 115,000,000
Amount of offering costs incurred		6,700,000
Amount of deferred underwriting commissions		$ 4,000,000
[1]	On October 14, 2020, the Sponsor effected a surrender of 431,250 Class B common shares to the Company for no consideration, resulting in a decrease in the total number of Class B common shares then outstanding from 3,737,500 to 3,306,250. All shares and associated amounts have been retroactively restated to reflect the share surrender (see Note 4).
[2]	Outstanding share amount included an aggregate of up to 431,250 Class B common shares that were subject to forfeiture depending on whether the underwriter’s over-allotment option was exercised (see Note 3).

Significant Accounting Polici_2

Significant Accounting Policies (Details)	2 Months Ended
	Sep. 30, 2020USD ($)shares
Accounting Policies [Abstract]
Federal depository insurance coverage | $	$ 250,000
Decreasing of weighted average shares | shares	431,250

Initial Public Offering (Detail

Initial Public Offering (Details) - USD ($) $ / shares in Units, $ in Millions	Nov. 16, 2020	Oct. 19, 2020	Sep. 30, 2020
Initial Public Offering (Details) [Line Items]
Price per unit			$ 1.50
Granted underwriter			1,725,000
Forfeited shares			431,250
Founder shares percentage	20.00%
Underwriting per unit			$ 0.20
Underwriting discount			$ 2.3
Aggregate payable per unit			$ 0.35
Aggregate payable amount			$ 4
Subsequent event [Member]
Initial Public Offering (Details) [Line Items]
Founder shares percentage	20.00%
Maximum [Member] | Subsequent event [Member]
Initial Public Offering (Details) [Line Items]
Common stock shares outstanding	3,306,250
Minimum [Member] | Subsequent event [Member]
Initial Public Offering (Details) [Line Items]
Common stock shares outstanding	2,875,000
Initial public offering [Member] | Subsequent event [Member]
Initial Public Offering (Details) [Line Items]
Initial public offering units		11,500,000
Price per unit		$ 10
Gross proceeds		$ 115
Offering costs		6.7
Deferred underwriting commissions		$ 4
Private placement [Member] | Subsequent event [Member]
Initial Public Offering (Details) [Line Items]
Price per unit		$ 10
Net proceeds		$ 115
Class A common stock [Member]
Initial Public Offering (Details) [Line Items]
Price per unit			$ 11.50
Common stock, par value			$ 0.0001
Common stock shares outstanding			0
Class A common stock [Member] | Initial public offering [Member] | Subsequent event [Member]
Initial Public Offering (Details) [Line Items]
Deferred underwriting commissions		$ 4

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)		Nov. 16, 2020	Aug. 18, 2020	Aug. 12, 2020	Sep. 30, 2020	Oct. 14, 2020
Related Party Transactions (Details) [Line Items]
Founder shares percentage		20.00%
Founder shares, description					(A) one year after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, (x) if the last reported sale price of the Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property.
Price per unit (in Dollars per share)					$ 1.50
Note payable (in Dollars)					$ 71,000
Working capital loans convertible into warrants (in Dollars)					$ 1,500,000
Private Placement Warrants [Member]
Related Party Transactions (Details) [Line Items]
Purchase of warrants					2,533,333
Price per unit (in Dollars per share)					$ 1.50
Gross proceeds (in Dollars)					$ 3,800,000
Subsequent Event [Member]
Related Party Transactions (Details) [Line Items]
Founder shares percentage		20.00%
Subsequent Event [Member] | Maximum [Member]
Related Party Transactions (Details) [Line Items]
Common stock, shares outstanding		3,306,250
Subsequent Event [Member] | Minimum [Member]
Related Party Transactions (Details) [Line Items]
Common stock, shares outstanding		2,875,000
Sponsor [Member]
Related Party Transactions (Details) [Line Items]
Loan to cover expenses (in Dollars)			$ 150,000
Chief Executive Officer [Member]
Related Party Transactions (Details) [Line Items]
Offering costs (in Dollars)				$ 25,000
Class B Common Stock [Member]
Related Party Transactions (Details) [Line Items]
Purchase of warrants	[1],[2]				3,306,250
Common stock, par value (in Dollars per share)					$ 0.0001
Shares surrendered						431,250
Common stock, shares outstanding					3,306,250
Class B Common Stock [Member] | Maximum [Member]
Related Party Transactions (Details) [Line Items]
Common stock, shares outstanding						3,737,500
Class B Common Stock [Member] | Subsequent Event [Member]
Related Party Transactions (Details) [Line Items]
Shares surrendered		431,250
Founder shares percentage		20.00%
Class B Common Stock [Member] | Subsequent Event [Member] | Maximum [Member]
Related Party Transactions (Details) [Line Items]
Common stock, shares outstanding		3,306,250
Class B Common Stock [Member] | Subsequent Event [Member] | Minimum [Member]
Related Party Transactions (Details) [Line Items]
Common stock, shares outstanding		2,875,000
Class B Common Stock [Member] | Chief Executive Officer [Member]
Related Party Transactions (Details) [Line Items]
Purchase of warrants				3,737,500
Class A Common Stock [Member]
Related Party Transactions (Details) [Line Items]
Purchase of warrants	[1],[2]
Common stock, par value (in Dollars per share)					$ 0.0001
Common stock, shares outstanding					0
Price per unit (in Dollars per share)					$ 11.50
[1]	On October 14, 2020, the Sponsor effected a surrender of 431,250 Class B common shares to the Company for no consideration, resulting in a decrease in the total number of Class B common shares then outstanding from 3,737,500 to 3,306,250. All shares and associated amounts have been retroactively restated to reflect the share surrender (see Note 4).
[2]	Outstanding share amount included an aggregate of up to 431,250 Class B common shares that were subject to forfeiture depending on whether the underwriter’s over-allotment option was exercised (see Note 3).

Stockholder's Equity (Details)

Stockholder's Equity (Details)	Nov. 16, 2020shares	Sep. 30, 2020$ / shares$ / itemshares	Oct. 14, 2020shares	Aug. 13, 2020shares
Stockholder's Equity (Details) [Line Items]
Founder shares percentage	20.00%
Preferred stock, shares authorized		1,000,000
Preferred stock par value (in Dollars per share) | $ / shares		$ 0.0001
Preferred stock, shares issued		0
Preferred stock, shares outstanding		0
Exercise price (in Dollars per share) | $ / shares		$ 11.50
Business combination consideration period		5 years
Issued price (in Dollars per share) | $ / shares		$ 9.20
Issuances of percentage		60.00%
Warrant price per unit (in Dollars per share) | $ / shares		$ 0.01
Common stock exceeds per unit (in Dollars per share) | $ / shares		$ 18
Redemption provided per unit (in Dollars per Item) | $ / item		0.10
Common stock exceeds price adjusted (in Dollars per share) | $ / shares		$ 10
Subsequent event [Member]
Stockholder's Equity (Details) [Line Items]
Founder shares percentage	20.00%
Maximum [Member] | Subsequent event [Member]
Stockholder's Equity (Details) [Line Items]
Common stock, shares outstanding	3,306,250
Minimum [Member] | Subsequent event [Member]
Stockholder's Equity (Details) [Line Items]
Common stock, shares outstanding	2,875,000
Warrant [Member]
Stockholder's Equity (Details) [Line Items]
Exercise price (in Dollars per share) | $ / shares		$ 9.20
Exercise price percentage		115.00%
Redemption percentage		18.00%
Issued price (in Dollars per share) | $ / shares		$ 1.80
Class A common stock [Member]
Stockholder's Equity (Details) [Line Items]
Common stock, shares authorized		50,000,000
Common stock, par value (in Dollars per share) | $ / shares		$ 0.0001
Common stock, shares issued		0
Common stock, shares outstanding		0
Class B common stock [Member]
Stockholder's Equity (Details) [Line Items]
Common stock, shares authorized		12,500,000
Common stock, par value (in Dollars per share) | $ / shares		$ 0.0001
Common stock, shares issued		3,306,250
Common stock, shares outstanding		3,306,250
Common stock voting rights		one
Converted basis percentage		20.00%
Class B common stock [Member] | Subsequent event [Member]
Stockholder's Equity (Details) [Line Items]
Sponsor shares			431,250
Forfeited shares	431,250
Founder shares percentage	20.00%
Class B common stock [Member] | Maximum [Member]
Stockholder's Equity (Details) [Line Items]
Common stock, shares outstanding			3,737,500
Class B common stock [Member] | Maximum [Member] | Subsequent event [Member]
Stockholder's Equity (Details) [Line Items]
Common stock, shares outstanding	3,306,250
Sponsor shares			3,737,500
Class B common stock [Member] | Minimum [Member] | Subsequent event [Member]
Stockholder's Equity (Details) [Line Items]
Common stock, shares outstanding	2,875,000
Sponsor shares			3,306,250
Stockholders' Equity Note, Changes in Capital Structure, Subsequent Changes to Number of Common Shares	2,875,000
Class B common stock [Member] | Sponsor [Member]
Stockholder's Equity (Details) [Line Items]
Common stock, shares issued				3,737,500